AQR Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-32,848
| Closed | -$3.19M | – | 2229 |
|
|
2019
Q3 | $3.19M | Hold |
32,848
| – | – | ﹤0.01% | 1116 |
|
|
2019
Q2 | $3.36M | Hold |
32,848
| – | – | ﹤0.01% | 1100 |
|
|
2019
Q1 | $3.74M | Buy |
+32,848
| New | +$2.41M | ﹤0.01% | 1084 |
|
|
2018
Q3 | – | Sell |
-6,236
| Closed | -$516K | – | 2367 |
|
|
2018
Q2 | $516K | Buy |
+6,236
| New | +$481K | ﹤0.01% | 1971 |
|
|
2018
Q1 | – | Sell |
-7,653
| Closed | -$394K | – | 2310 |
|
|
2017
Q4 | $394K | Buy |
7,653
+4,550
| +147% | +$327K | ﹤0.01% | 1992 |
|
|
2017
Q3 | $277K | Sell |
3,103
-6,791
| -69% | -$516K | ﹤0.01% | 2101 |
|
|
2017
Q2 | $591K | Sell |
9,894
-411
| -4% | -$23K | ﹤0.01% | 1834 |
|
|
2017
Q1 | $550K | Sell |
10,305
-9,507
| -48% | -$564K | ﹤0.01% | 1859 |
|
|
2016
Q4 | $989K | Sell |
19,812
-8,356
| -30% | -$448K | ﹤0.01% | 1696 |
|
|
2016
Q3 | $1.69M | Sell |
28,168
-1,847
| -6% | -$106K | ﹤0.01% | 1495 |
|
|
2016
Q2 | $1.53M | Buy |
30,015
+10,190
| +51% | +$435K | ﹤0.01% | 1435 |
|
|
2016
Q1 | $585K | Buy |
+19,825
| New | +$625K | ﹤0.01% | 1777 |
|
AQR Capital Management's ONCE Position: Q4 2019 in Review
AQR Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 32,848 shares — an estimated $3.19M sold.
AQR Capital Management first reported a position in ONCE in Q1 2016 and held it in 12 quarters. The position peaked at $3.74M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- AQR Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- AQR Capital Management sold 32,848 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3.19M.
- AQR Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 12 quarters.
- AQR Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $3.74M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.